Filing Details

Accession Number:
0001179110-15-010129
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-22 16:17:42
Reporting Period:
2015-06-18
Filing Date:
2015-06-22
Accepted Time:
2015-06-22 16:17:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1229450 A Craig Wheeler C/O Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge MA 02142
President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-18 125,000 $16.18 343,312 No 4 M Direct
Common Stock Disposition 2015-06-18 125,000 $24.22 218,312 No 4 S Direct
Common Stock Disposition 2015-06-18 30,000 $24.11 181,032 No 4 S Indirect Craig Wheeler Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Indirect Craig Wheeler Revocable Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-06-18 125,000 $0.00 125,000 $16.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
125,000 2010-08-22 2016-08-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 150,000 Indirect Craig A. Wheeler 2014 Irrevocable Trust
Footnotes
  1. This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on June 14, 2013.
  2. This transaction was executed in multiple trades at prices ranging from $24.00 to $24.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This sale was effected pursuant to a Rule 10b5-1 Craig Wheeler Revocable Trust trading plan adopted by the reporting person on June 14, 2013.
  4. This transaction was executed in multiple trades at prices ranging from $24.00 to $24.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.